Zagazig University Hospitals
Zagazig, Sharqia Province, 44519, Egypt
NCT Number: NCT01560702
Endoscopic injection of autologous blood can control bleeding from gastroduodenal ulcers.
Looking for future studies?
Notify Me16 year–60 year
All sexes
Interventional
Not applicable
Zagazig, Sharqia Province, 44519, Egypt
To test the hypothesis that endoscopic injection of autologous blood is superior to endoscopic injection of diluted epinephrine in controlling bleeding from gastroduodenal ulcers.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
10-30 cc of 1/10000 diluted epinephrine will be injected at edges of an actively bleeding ulcer.
5-20 cc autologous blood immediately withdrawn from the patient will be injected at edges of the actively bleeding ulcer.
Time frame: 12 months
Time frame: 12 months
Zagazig University
Other Gov
Endoscopic Injection of Autologous Blood Versus Diluted Epinephrine for Control of Actively Bleeding Gastroduodenal Ulcers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06336031
Autonomic Nervous System Diseases, Blood, Injection, Injury Type Phobia
Burnaby, British Columbia, Canada
View Trial DetailsNCT07737184
Cardiovascular Diseases, Diabetes Complications
Ostrava, Czechia
View Trial DetailsNCT03602599
Autoimmune Diseases, Graft Versus Host Disease
Bethesda, Maryland, United States
View Trial DetailsNCT04272307
Colitis, Colonic Diseases
Bordeaux, France
View Trial Details